Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

84 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

NCT02061761

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Local Institution - 0007 Baltimore, Maryland, United States
  • Local Institution - 0004 Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Local Institution - 0010 St Louis, Missouri, United States
View Trial Details
Completed

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

NCT02623309

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • CHU Amiens Amiens, France
  • CHU Besançon Besançon, France
  • CHU Estaing/Clermont-ferrand Clermont-Ferrand, France
  • CHU Albert Michallon Grenoble, France
View all 14 locations
View Trial Details
Completed

Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

NCT04264767

Conditions
Cancer, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations
  • Los Angeles Hematology Oncology Medical Group - Wilson Terrace Glendale, California, United States
  • Los Angeles Hematology Oncology Medical Group - Good Samaritan Medical Offices Los Angeles, California, United States
  • Sourasky Medical Center Tel Aviv, Israel
View Trial Details
Completed

A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

NCT02367196

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Completed

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

NCT00526045

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • UCLA/ University of California Los Angeles UCLA Los Angeles, California, United States
  • Georgia Health Sciences University Med College of GA Augusta, Georgia, United States
  • Dana Farber Cancer Institute StudyCoordinator:CAUY922A2101 Boston, Massachusetts, United States
  • Washington University School Of Medicine-Siteman Cancer Ctr Dept. of Siteman Cancer Ctr. St Louis, Missouri, United States
View Trial Details
Completed

National Marrow Donor Program Long-Term Donor Follow-Up

NCT01362179

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope Duarte, California, United States
  • National Marrow Donor Program Northern California & Northwest District Oakland, California, United States
  • National Marrow Donor Program Southern California & Southwest District Santa Ana, California, United States
  • Colorado Marrow Donor Program Denver, Colorado, United States
View all 29 locations
View Trial Details

Related conditions